DISAB

Connect with us

National

Inflammasome Therapeutics Says Study of Approximately 130000 People Reported in Nature Communications Points to Potential for Treatment or Prevention of Diabetes and Other Inflammasome-Mediated Diseases with Company’s Drugs – Business Wire

Inflammasome Therapeutics says study in Nature Communications points to potential treatment or prevention of diabetes with company’s drugs

Published

on

post featured image

NEWTON, Mass.–(BUSINESS WIRE)–Inflammasome Therapeutics (http://www.inflam.com), a privately held company developing therapies for prevalent, degenerative diseases, reported that data analyses published today in Nature Communications https://www.nature.com/articles/s41467-020-18528-z showed that patients taking nucleoside reverse transcriptase inhibitors (NRTIs), drugs used to treat HIV for more than 30 years, reduced their risk of developing type 2 diabetes by 33%, a highly statistically sign…

Click here to view the original article.

Safety Mate